Immunogenicity and Safety of PCV-free Liquid Rotarix Co-administered with Routine Infant Vaccines

Phase 3, randomised, open-label trial of rotavirus vaccine, live, oral in rotavirus infection (2 arms), sponsored by GSK. Primary endpoints: Number of Seroprotected Subjects With Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibody Concentrations Above or Equal to Cut-off Value at Month 5, Number of Seroprotected Subjects With Anti-hepatitis B (Anti-HBs) Antibody Concentrations Above or Equal to Cut-off Value at Month 5 and 6 more. Started Sep 2017; status: completed.